Industry News
Biotechnology Industry News
New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns
New antibiotics still a decade away unless policymakers, investors step up, AMR Action Fund CEO warns gmasson Thu, 04/07/2022 - 18:05
Chutes & Ladders—Fierce Biotech launches Layoff Tracker amid dizzying number of industry job cuts
Chutes & Ladders—Fierce Biotech launches Layoff Tracker amid dizzying number of industry job cuts mbayer Thu, 04/07/2022 - 16:29
Pandemic tears up Biophytis’ plans, limiting data and blowing up timelines
Pandemic tears up Biophytis' plans, limiting data and blowing up timelines gmasson Thu, 04/07/2022 - 13:21
Takeda spinout HilleVax goes public, a test of the choppy waters for biotechs on Wall Street
Takeda spinout HilleVax goes public, a test of the choppy waters for biotechs on Wall Street mbayer Thu, 04/07/2022 - 10:17
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact aarmstrong Thu, 04/07/2022 - 08:47
Moderna partners with nonprofit to use mRNA to address global health challenges
Moderna partners with nonprofit to use mRNA to address global health challenges aarmstrong Thu, 04/07/2022 - 08:19
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on aarmstrong Thu, 04/07/2022 - 07:53
ArkBio’s ex-Roche antiviral hits primary goal in RSV phase 3, sparking race to regulator and wait for more data
ArkBio's ex-Roche antiviral hits primary goal in RSV phase 3, sparking race to regulator and wait for more data ntaylor Thu, 04/07/2022 - 06:25
AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights
AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights ntaylor Thu, 04/07/2022 - 05:20
Gilead unveils pediatric drug development center in Ireland with 33 new jobs
Gilead unveils pediatric drug development center in Ireland with 33 new jobs gmasson Wed, 04/06/2022 - 14:06
Athira board spares no punches to fend off proxy fight from ally of ousted CEO
Athira board spares no punches to fend off proxy fight from ally of ousted CEO mbayer Wed, 04/06/2022 - 10:15
Path cleared for Iovance’s lead melanoma drug after FDA assay feedback
Path cleared for Iovance's lead melanoma drug after FDA assay feedback aarmstrong Wed, 04/06/2022 - 10:01
20 years in, Genentech persists and perseveres in Alzheimer’s with gantenerumab
20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab aarmstrong Wed, 04/06/2022 - 09:07
Belite Bio hits go on IPO to fund late-phase vision loss clinical trials
Belite Bio hits go on IPO to fund late-phase vision loss clinical trials ntaylor Wed, 04/06/2022 - 08:23
FDA oncology chief aims to open up accelerated approval for earlier cancer treatment under ‘Project FrontRunner’
FDA oncology chief aims to open up accelerated approval for earlier cancer treatment under 'Project FrontRunner' aliu Wed, 04/06/2022 - 07:57
Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact
Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact ntaylor Wed, 04/06/2022 - 06:49
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda gmasson Tue, 04/05/2022 - 17:29
Merck looks to cardiovascular pipeline for $10B-plus peak sales—and diversification from Keytruda
Merck looks to cardiovascular pipeline for $10B-plus peak sales—and diversification from Keytruda gmasson Tue, 04/05/2022 - 17:29
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021 aarmstrong Tue, 04/05/2022 - 13:56
String of NIH departures continues as Ned Sharpless, head of the National Cancer Institute, steps down
String of NIH departures continues as Ned Sharpless, head of the National Cancer Institute, steps down mbayer Tue, 04/05/2022 - 09:54